Drug Induced Ectropion: a Systematic Review
Journal of Ophthalmic and Optometric Sciences,
Vol. 3 No. 3 (2019),
10 July 2019
,
Page 61-72
https://doi.org/10.22037/joos.v2i4.30663
Abstract
Background: To review etiologies, risk factors, management and prognosis of drug induced ectropion as a rare entity.
Material and Methods: In this systematic review, we reviewed all related published articles in English literature until April 2019 by searching Pubmed resources using the keywords ‘drug induced ectropion’.
Results: We found 26 relevant articles describing 48 patients with drug induced ectropion. The patient mean
age was 67.4 years (range 15-93 years). Different topical and systemic drugs were reported as the causing agents including chemotherapeutic (45.8 %) drugs as the most frequent cause (22 patients, including 5 patients using topical fluorouracil, 9 patients using systemic fluorouracil, 7 patients using epidermal growth factor receptor inhibitors, and 1 patient using docetaxel), followed by topical anti-glaucoma (39.5 %) drugs (19 patients). The mean interval between starting the drug usage and emergence of ectropion was 9.74 months (range 1 day-72 months). Cessation of the causing drug and conservative treatments including topical lubricants, antibiotics and steroids were the most common management method. Surgery was required only in 10 patients (20.8 %).
Conclusion: Drug induced ectropion can develop following the administration of various topical and systemic drugs. Discontinuation of the causing drug and conservative treatments including topical steroids are often successful in managing the ectropion. Surgical treatment is scarcely needed among patients with drug induced ectropion.
Keywords: Drug Induced; Ectropion; Systematic review.
- Drug Induced
- Ectropion
- Systematic review
How to Cite
References
Bedran EG, Pereira MV, Bernardes TF. Ectropion. Semin Ophthalmol. 2010 May;25(3):59-65.
Vallabhanath P, Carter SR. Ectropion and entropion. Curr Opin Ophthalmol. 2000;11(5):345-51.
Piskiniene R. Eyelid malposition: lower lid entropion and ectropion. Medicina (Kaunas). 2006;42(11):881-4.
Hegde V, Robinson R, Dean F, Mulvihill HA, Ahluwalia H. Drug-induced ectropion: what is best practice? Ophthalmology. 2007;114(2):362-6.
Aristodemou P, Baer R. Reversible cicatricial ectropion precipitated by topical brimonidine eye drops. Ophthalmic Plast Reconstr Surg. 2008;24(1):57-8.
Bartley GB. Reversible lower eyelid ectropion associated with dipivefrin. Am J Ophthalmol. 1991;111(5):650-1.
Custer PL, Kent TL. Observations on Prostaglandin Orbitopathy. Ophthalmic Plast Reconstr Surg. 2016;32(2):102-5.
Britt MT, Burnstine MA. Iopidine allergy causing lower eyelid ectropion progressing to cicatricial entropion. Br J Ophthalmol. 1999;83(8):992–3.
Lewis JE. Temporary ectropion due to topical fluorouracil. Int J Dermatol. 1997;36(1):79.
Nikkhah D, Abood A, Watt D. Cicatricial ectropion: a complication of topical 5-fluorouracil. J Plast Reconstr Aesthet Surg. 2012;65(1):e9-10.
Tsui M, Tajirian A. Cicatricial Ectropion With Topical 5% Fluorouracil Cream. Dermatol Surg. 2016;42(8):1005-6.
Wojno T, Tenzel RR. Lower eyelid ectropion following chemical face peeling. Ophthalmic Surgery. 1984;15(7):596-7.
Kaiserman I, Kaiserman N. Severe blepharoconjunctivitis induced by a peeling mask containing trichloroacetic acid. Ocul Immunol Inflamm. 2005;13(2-3):257-9.
Brodell LP, Asselin D, Brodell RT. Reversible ectropion after long-term use of topical tretinoin on photodamaged skin. J Am Acad Dermatol. 1992;27(4):621-2.
Tatar S, Yalçın CE, Sezgin B, Taş AY, Müftüoğlu O, Özmen S. Capecitabine-Induced Bilateral Ectropion: A Rare Ocular Manifestation Requiring Surgical Intervention. J Cutan Aesthet Surg. 2018;11(4):241-4.
Obi EE, McDonald A, Kemp E. A bilateral cicatricial ectropion and bilateral upper lid shortening caused by 5-fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency. Cutan Ocul Toxicol. 2011;30(2):157-9.
Eiseman AS, Flanagan JC, Brooks AB, Mitchell EP, Pemberton CH. Ocular surface, ocular adnexal, and lacrimal complications associated with the use of systemic 5-fluorouracil. Ophthalmic Plast Reconstr Surg. 2003;19(3):216-24.
Straus DJ, Mausolf FA, Ellerby RA, McCracken JD. Cicatricial ectropion secondary to 5-fluorouracil therapy. Med Pediatr Oncol. 1977;3(1):15-9.
Hurwitz BS. Cicatricial ectropion: a complication of systemic fluorouracil. Arch Ophthalmol. 1993;111(12):1608-9.
Frankfort BJ, Garibaldi DC. Periocular cutaneous toxicity and cicatricial ectropion: a potential class effect of antineoplastic agents that inhibit EGFR signaling. Ophthalmic Plast Reconstr Surg. 2007;23(6):496-7.
Garibaldi DC, Adler RA. Cicatricial ectropion associated with treatment of metastatic colorectal cancer with cetuximab. Ophthalmic Plast Reconstr Surg. 2007;23(1):62-3.
Scofield-Kaplan S, Todaro J, Winn BJ. Reversible cicatricial ectropion associated with EGFR inhibitors. Orbit. 2018;37(5):364-7.
Salman A, Cerman E, Seckin D, Kanitez M. Erlotinib induced ectropion following papulopustular rash. J Dermatol Case Rep. 2015;9(2):46-8.
Kaya AO, Buyukberber S, Coskun U, Yildiz R, Ozturk B, Yaman E, etal. Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer. Cutan Ocul Toxicol. 2008;27(4):327-31.
Brenner S, Wolf R, Landau M. Ectropion: an adverse effect of etretinate therapy for psoriasis. DICP. 1990;24(10):1007.
Teo HMT, de Sá Freire F, Demirci H. Association of Blepharitis and Ectropion With Tumor Necrosis Factor α Inhibitor Treatment in Crohn Disease. JAMA Ophthalmol. 2019;137(2):232-3.
Barnes AC, Blandford AD, Perry JD. Cicatricial ectropion in a patient treated with dupilumab. Am J Ophthalmol Case Rep. 2017;7:120-2.
Saint-Jean A, Sainz de la Maza M, Morral M, Torras J, Quintana R, Molina JJ, et al. Ocular adverse events of systemic inhibitors of the epidermal growth factor receptor: report of 5 cases. Ophthalmology. 2012;119(9):1798-802.
Methvin AB, Gausas RE. Newly recognized ocular side effects of erlotinib. Ophthalmic Plast Reconstr Surg. 2007;23(1):63-5.
Dailey RA, Gray JF, Rubin MG, Hildebrand PL, Swanson NA, Wobig JL, et al. Histopathologic changes of the eyelid skin following trichloroacetic acid chemical peel. Ophthalmic Plast Reconstr Surg. 1998;14(1):9-12.
Vatrella A, Fabozzi I, Calabrese C, Maselli R, Pelaia G. Dupilumab: a novel treatment for asthma. J Asthma Allergy. 2014;7:123-30.
- Abstract Viewed: 97 times
- pdf Downloaded: 119 times
